Alyeska Investment Group’s Labcorp LH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $99.7M | Buy |
373,622
+188,622
| +102% | +$51.1M | 0.28% | 99 |
|
|
2025
Q4 | $46.4M | Buy |
185,000
+181,738
| +5,571% | +$48.3M | 0.13% | 192 |
|
|
2025
Q3 | $936K | Sell |
3,262
-446,160
| -99% | -$120M | ﹤0.01% | 544 |
|
|
2025
Q2 | $118M | Sell |
449,422
-65,406
| -13% | -$15.9M | 0.42% | 58 |
|
|
2025
Q1 | $120M | Buy |
514,828
+70,550
| +16% | +$17.1M | 0.48% | 58 |
|
|
2024
Q4 | $102M | Sell |
444,278
-21,059
| -5% | -$4.83M | 0.38% | 63 |
|
|
2024
Q3 | $104M | Buy |
465,337
+65,568
| +16% | +$14.4M | 0.53% | 45 |
|
|
2024
Q2 | $81.4M | Buy |
+399,769
| New | +$81.3M | 0.47% | 65 |
|
|
2023
Q2 | – | Sell |
-190,649
| Closed | -$37.6M | – | 597 |
|
|
2023
Q1 | $37.6M | Buy |
+190,649
| New | +$39.2M | 0.33% | 100 |
|
|
2020
Q2 | – | Sell |
-41,256
| Closed | -$4.48M | – | 541 |
|
|
2020
Q1 | $4.48M | Sell |
41,256
-78,875
| -66% | -$11.4M | 0.09% | 200 |
|
|
2019
Q4 | $17.5M | Buy |
120,131
+9,487
| +9% | +$1.37M | 0.23% | 134 |
|
|
2019
Q3 | $16M | Buy |
110,644
+31,855
| +40% | +$4.65M | 0.23% | 133 |
|
|
2019
Q2 | $11.7M | Sell |
78,789
-58,617
| -43% | -$8.18M | 0.15% | 157 |
|
|
2019
Q1 | $18.1M | Sell |
137,406
-197,449
| -59% | -$24.3M | 0.24% | 130 |
|
|
2018
Q4 | $36.4M | Sell |
334,855
-168,329
| -33% | -$22.5M | 0.53% | 64 |
|
|
2018
Q3 | $75.1M | Buy |
+503,184
| New | +$76.5M | 0.82% | 34 |
|
|
2017
Q3 | – | Sell |
-20,719
| Closed | -$2.74M | – | 502 |
|
|
2017
Q2 | $2.74M | Sell |
20,719
-1,070,408
| -98% | -$131M | 0.02% | 321 |
|
|
2017
Q1 | $134M | Buy |
1,091,127
+227,607
| +26% | +$26.9M | 1.09% | 8 |
|
|
2016
Q4 | $95.2M | Buy |
863,520
+299,727
| +53% | +$33.3M | 0.79% | 21 |
|
|
2016
Q3 | $66.6M | Buy |
+563,793
| New | +$66.4M | 0.62% | 37 |
|
|
2015
Q2 | – | Sell |
-292,520
| Closed | -$31.7M | – | 535 |
|
|
2015
Q1 | $31.7M | Sell |
292,520
-238,894
| -45% | -$24.6M | 0.44% | 80 |
|
|
2014
Q4 | $49.3M | Buy |
+531,414
| New | +$46.9M | 0.84% | 9 |
|
|
2014
Q2 | – | Sell |
-130,815
| Closed | -$11M | – | 429 |
|
|
2014
Q1 | $11M | Buy |
+130,815
| New | +$10.4M | 0.3% | 129 |
|
|
2013
Q4 | – | Sell |
-100,103
| Closed | -$8.53M | – | 350 |
|
|
2013
Q3 | $8.53M | Sell |
100,103
-29,100
| -23% | -$2.45M | 0.35% | 102 |
|
|
2013
Q2 | $11.1M | Buy |
+129,203
| New | +$10.7M | 0.55% | 58 |
|
Other funds holding LH
VCM
VPM
Alyeska Investment Group's LH Position: Q1 2026 in Review
Alyeska Investment Group increased its Labcorp (LH) stake by 102% in Q1 2026, buying an estimated $51.1M and bringing the position to 373,622 shares worth $99.7M. The position accounts for 0.28% of the portfolio, ranked #99.
Alyeska Investment Group first reported a position in LH in Q2 2013 and has held it in 25 quarters since. The position peaked at $134M in Q1 2017. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.
- Alyeska Investment Group held 373,622 shares of Labcorp worth $99.7M as of Q1 2026.
- Alyeska Investment Group bought 188,622 Labcorp shares in Q1 2026, an estimated $51.1M.
- Labcorp made up 0.28% of Alyeska Investment Group's portfolio in Q1 2026, its #99 holding.
- Alyeska Investment Group first reported a position in Labcorp in Q2 2013 and has held it in 25 quarters since.
- Alyeska Investment Group's Labcorp position peaked at $134M in Q1 2017.
- 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.
Based on Alyeska Investment Group's 13F filing for Q1 2026, filed 15 May 2026.